Author

B. Westwood

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

K. L. Cook· 3 shared A. S. Wilson· 2 shared D. R. Soto-Pantoja· 2 shared E. R. Stirling· 2 shared G. J. Lesser· 2 shared A. J. Wilson· 1 shared A. Thomas· 1 shared B. A. Kerr· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

K. L. Cook

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 25, 2023

Anti-CD47 immunotherapy as a therapeutic strategy for the treatment of breast cancer brain metastasis

J. D. Mackert, E. R. Stirling, A. S. Wilson…·D. R. Soto-Pantoja

This study shows that blocking CD47 reduces brain metastasis in breast cancer by enhancing immune response and altering tumor microenvironment signaling.

DOI 10.1101/2023.07.25.550566

mouseproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJul 12, 2023

Absence of CD47 in the tumor microenvironment modulates tumor metabolism and immunosuppressive signatures limiting breast cancer progression.

E. R. Stirling, Y.-T. Tsai, S. M. Bronson…·D. R. Soto-Pantoja

This paper shows that CD47 absence in tumors reduces tumor burden and enhances immune response by altering metabolism and immunosuppressive signatures in breast cancer.

DOI 10.1101/2023.07.12.548766

mousehuman

𝕏 PostBluesky

Cancer BiologybioRxivPreprintSep 16, 2021

A Novel Model of Estrogen Receptor-Positive Breast Cancer Bone Metastasis with Antiestrogen Responsiveness

K. L. Langsten, L. Shi, A. S. Wilson…·B. A. Kerr

This paper develops an immunocompetent ER+ breast cancer mouse model with spontaneous bone metastasis and antiestrogen responsiveness, showing treatment efficacy with tamoxifen and fulvestrant.

DOI 10.1101/2021.09.16.460665

mousebulk RNA-seq

𝕏 PostBluesky